JP2022506749A5 - - Google Patents

Info

Publication number
JP2022506749A5
JP2022506749A5 JP2021524328A JP2021524328A JP2022506749A5 JP 2022506749 A5 JP2022506749 A5 JP 2022506749A5 JP 2021524328 A JP2021524328 A JP 2021524328A JP 2021524328 A JP2021524328 A JP 2021524328A JP 2022506749 A5 JP2022506749 A5 JP 2022506749A5
Authority
JP
Japan
Prior art keywords
item
composition
crosslinkable
entity
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021524328A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022506749A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/059553 external-priority patent/WO2020093022A1/en
Publication of JP2022506749A publication Critical patent/JP2022506749A/ja
Publication of JP2022506749A5 publication Critical patent/JP2022506749A5/ja
Priority to JP2024184029A priority Critical patent/JP2025011292A/ja
Pending legal-status Critical Current

Links

JP2021524328A 2018-11-02 2019-11-01 架橋される材料 Pending JP2022506749A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024184029A JP2025011292A (ja) 2018-11-02 2024-10-18 架橋される材料

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862754995P 2018-11-02 2018-11-02
US62/754,995 2018-11-02
PCT/US2019/059553 WO2020093022A1 (en) 2018-11-02 2019-11-01 Crosslinked materials

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024184029A Division JP2025011292A (ja) 2018-11-02 2024-10-18 架橋される材料

Publications (2)

Publication Number Publication Date
JP2022506749A JP2022506749A (ja) 2022-01-17
JP2022506749A5 true JP2022506749A5 (cg-RX-API-DMAC7.html) 2022-11-09

Family

ID=68655736

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021524328A Pending JP2022506749A (ja) 2018-11-02 2019-11-01 架橋される材料
JP2024184029A Pending JP2025011292A (ja) 2018-11-02 2024-10-18 架橋される材料

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024184029A Pending JP2025011292A (ja) 2018-11-02 2024-10-18 架橋される材料

Country Status (8)

Country Link
US (2) US12311048B2 (cg-RX-API-DMAC7.html)
EP (1) EP3873431A1 (cg-RX-API-DMAC7.html)
JP (2) JP2022506749A (cg-RX-API-DMAC7.html)
KR (2) KR20250133796A (cg-RX-API-DMAC7.html)
CN (1) CN113365602A (cg-RX-API-DMAC7.html)
CA (1) CA3118491A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202109443QA (cg-RX-API-DMAC7.html)
WO (1) WO2020093022A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12311048B2 (en) 2018-11-02 2025-05-27 Fount Bio, Inc. Crosslinked materials
WO2020214889A1 (en) * 2019-04-19 2020-10-22 Fount Bio, Inc. Delivery and retention of active agents within the skin
DE102020125546A1 (de) 2020-09-30 2022-03-31 Leibniz-Institut Für Neue Materialien Gemeinnützige Gesellschaft Mit Beschränkter Haftung Neuartige Hydrogele
EP4237022A1 (en) * 2020-10-28 2023-09-06 Fount Bio, Inc. Transdermal delivery
AU2024255997A1 (en) * 2023-04-11 2025-10-30 The Board Of Trustees Of The University Of Illinois Phase change materials with enhanced thermal stability
WO2024254278A2 (en) * 2023-06-08 2024-12-12 Fount Bio, Inc. Ophthalmic films

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902652D0 (en) 1999-02-05 1999-03-31 Fermentech Med Ltd Process
US8038991B1 (en) * 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
FR2857266B1 (fr) 2003-07-07 2007-09-21 Jean Noel Thorel Composition a usage dermatologique et/ou cosmetique, comprenant a titre de principe actif au moins un antioxydant lipophile
US20060008428A1 (en) 2004-06-16 2006-01-12 L'oreal Method of promoting the penetration of a cosmetic active and composition therefore
WO2007024026A1 (ja) 2005-08-25 2007-03-01 Taiho Pharmaceutical Co., Ltd. T細胞認識エピトープペプチドを固定化又は内包化した生分解性ナノ粒子
AU2006320556A1 (en) 2005-12-01 2007-06-07 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Isotopically-labeled benzothiazole compounds as imaging agents for amyloidogenic proteins
US7750106B2 (en) * 2005-12-21 2010-07-06 Avon Products, Inc. Cosmetic compositions having in-situ hydrosilylation cross-linking
TWI436793B (zh) * 2006-08-02 2014-05-11 巴克斯特國際公司 快速作用之乾密封膠及其使用和製造方法
EP2254944B1 (en) * 2008-02-29 2018-12-19 PVAC Medical Technologies Ltd. Composition for the formation of gels
JP5905402B2 (ja) 2010-03-11 2016-04-20 プロメガ コーポレイションPromega Corporation シアノベンゾチアゾール化合物を使用する生物発光アッセイ
US8735386B2 (en) 2010-07-23 2014-05-27 Boehringer Ingelheim International Gmbh Aminopyrazoloquinazolines
US20140256831A1 (en) 2011-05-31 2014-09-11 The University Of Tokyo Hydrogel and method for producing same
US20130096081A1 (en) * 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9655967B2 (en) * 2011-12-09 2017-05-23 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of focal adhesion kinase for control of scar tissue formation
ES2571479T3 (es) 2012-04-20 2016-05-25 Gilead Sciences Inc Derivados del ácido benzotiazol-6-il acético y su uso para tratar una infección por VIH
EP2719703A1 (en) 2012-10-12 2014-04-16 Ecole Polytechnique Fédérale de Lausanne (EPFL) Precursor molecule for the synthesis of D-luciferin
US20140227174A1 (en) 2013-02-11 2014-08-14 The Regents Of The University Of California Skin permeating and cell entering (space) peptides and methods of use therefor
US10624865B2 (en) 2013-03-14 2020-04-21 Pathak Holdings Llc Methods, compositions, and devices for drug/live cell microarrays
WO2014178878A1 (en) 2013-05-03 2014-11-06 Yale University Synthetic antibody mimetic compounds (syams) targeting cancer, especially prostate cancer
WO2016010092A1 (ja) 2014-07-16 2016-01-21 国立研究開発法人科学技術振興機構 ベンゾチアゾール化合物及びこれを含有する医薬
EP4368208A3 (en) * 2015-06-11 2024-07-17 The Regents of University of California Novel hyaluronic acid-based hydrogels having medical applications
SG11201808528VA (en) * 2016-03-30 2018-10-30 Convatec Technologies Inc Modified wound dressings
US20170348218A1 (en) 2016-06-03 2017-12-07 Sanova Bioscience Inc Microneedle patch containing hyaluronic acid for cosmetic use
US12311048B2 (en) 2018-11-02 2025-05-27 Fount Bio, Inc. Crosslinked materials
WO2020214889A1 (en) 2019-04-19 2020-10-22 Fount Bio, Inc. Delivery and retention of active agents within the skin
EP4237022A1 (en) 2020-10-28 2023-09-06 Fount Bio, Inc. Transdermal delivery

Similar Documents

Publication Publication Date Title
Yu et al. Polymer microneedles fabricated from alginate and hyaluronate for transdermal delivery of insulin
Zhang et al. Poly (ester amide)-based hybrid hydrogels for efficient transdermal insulin delivery
Yao et al. Flexible two-layer dissolving and safing microneedle transdermal of neurotoxin: A biocomfortable attempt to treat Rheumatoid Arthritis
Yu et al. Systematic comparisons of dissolving and swelling hyaluronic acid microneedles in transdermal drug delivery
JP6997470B2 (ja) ガロール基で修飾されたヒアルロン酸誘導体を基材とするヒドロゲルおよびその用途
Cheng et al. Neural stem cells encapsulated in a functionalized self-assembling peptide hydrogel for brain tissue engineering
Aghmiuni et al. Quince seed mucilage-based scaffold as a smart biological substrate to mimic mechanobiological behavior of skin and promote fibroblasts proliferation and h-ASCs differentiation into keratinocytes
US20200353127A1 (en) Collagen peptide-containing polycaprolactone microsphere filler and preparation method therefor
Jin et al. Polyphenol-mediated hyaluronic acid/tannic acid hydrogel with short gelation time and high adhesion strength for accelerating wound healing
Lee et al. In situ self-cross-linkable, long-term stable hyaluronic acid filler by gallol autoxidation for tissue augmentation and wrinkle correction
AU2012247089B2 (en) Microneedle assembly formulation for skin treatment
US20250325638A1 (en) Vivo synthesis of elastic fiber
Maghdouri-White et al. Mammary epithelial cell adhesion, viability, and infiltration on blended or coated silk fibroin–collagen type I electrospun scaffolds
KR101967153B1 (ko) 주름과 피부 결손 및 위축성 흉터 개선을 위한 필러 배합 조성물
Men et al. Microneedle patch-assisted transdermal administration of recombinant hirudin for the treatment of thrombotic diseases
KR101926751B1 (ko) 피부 충진용 필러 및 이의 제조방법
Goonoo Tunable biomaterials for myocardial tissue regeneration: promising new strategies for advanced biointerface control and improved therapeutic outcomes
CN107814853A (zh) 适合用于美容和药物用途的外用透皮糖胺聚糖制剂
Yoon et al. Differential regeneration of myocardial infarction depending on the progression of disease and the composition of biomimetic hydrogel
CN104921961B (zh) 一种多效修复的可降解生物微针贴
CN110691579A (zh) 用于治疗的肉毒杆菌神经毒素
CN113365602A (zh) 交联材料
Si et al. Control-released basic fibroblast growth factor-loaded poly-lactic-co-glycolic acid microspheres promote sciatic nerve regeneration in rats
Zhang et al. Microneedle drug delivery system based on hyaluronic acid for improving therapeutic efficiency of hypertrophic scars
KR20180035032A (ko) 가교 히알루론산을 포함하는 주사용 조성물